These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 4528847
1. Urinary pyrrole pigments in thalassemia and unstable hemoglobin diseases. Kreimer-Birnbaum M, Rusnak PA, Bannerman RM, Glass U. Ann N Y Acad Sci; 1974; 232(0):283-92. PubMed ID: 4528847 [No Abstract] [Full Text] [Related]
2. Dipyrrolic urinary pigments in congenital Heinz-body anaemia due to Hb köln and in thalassaemia. Kreimer-Birnbaum M, Pinkerton PH, Bannerman RM, Hutchison HE. Br Med J; 1966 Aug 13; 2(5510):396. PubMed ID: 5917360 [No Abstract] [Full Text] [Related]
3. Recent studies on pyrrole metabolism in thalassemia. Kreimer-Birnbaum M, Bannerman RM, Pinkerton PH. Ann N Y Acad Sci; 1969 Nov 20; 165(1):185-93. PubMed ID: 5260141 [No Abstract] [Full Text] [Related]
4. Interaction of alpha-thalassemia with other hemoglobinopathies in the eastern province of Saudi Arabia. Sumer T, Ahmad M, Al-Mouzan M, Al-Awamy B. Birth Defects Orig Artic Ser; 1987 Nov 20; 23(5A):343-7. PubMed ID: 3689916 [No Abstract] [Full Text] [Related]
5. Unstable hemoglobins and thalassemia: some properties of Hb Köln. Ranney HM, Sharma VS, Noble RW. Ann N Y Acad Sci; 1974 Nov 20; 232(0):293-6. PubMed ID: 4370538 [No Abstract] [Full Text] [Related]
6. RELATIONSHIP OF ERYTHROCYTE SURVIVAL AND RETICULOCYTE LEVELS TO SPLENECTOMY AND NEED FOR TRANSFUSION IN THALASSEMIA MAJOR. WOLFF JA, ULTMANN JE, SITARZ A. Ann N Y Acad Sci; 1964 Oct 07; 119():686-93. PubMed ID: 14219447 [No Abstract] [Full Text] [Related]
7. Urinary iron excretion in thalassaemia after desferrioxamine administration. Seshadri R, Colebatch JH, Fisher R. Arch Dis Child; 1974 Mar 07; 49(3):195-9. PubMed ID: 4825624 [Abstract] [Full Text] [Related]
8. ABNORMALITIES OF HEME AND PYRROLE METABOLISM IN THALASSEMIA. BANNERMAN RM. Ann N Y Acad Sci; 1964 Oct 07; 119():503-12. PubMed ID: 14219429 [No Abstract] [Full Text] [Related]
9. Carrier screening for thalassemia and hemoglobinopathies in Canada. Langlois S, Ford JC, Chitayat D, CCMG PRENATAL DIAGNOSIS COMMITTEE, SOGC GENETICS COMMITTEE. J Obstet Gynaecol Can; 2008 Oct 07; 30(10):950-959. PubMed ID: 19038079 [Abstract] [Full Text] [Related]
16. Transfusion-induced hemoglobinopathy in patients of beta-thalassemia major. Gupta SK, Sharma M, Tyagi S, Pati HP. Indian J Pathol Microbiol; 2011 Oct 07; 54(3):609-11. PubMed ID: 21934236 [Abstract] [Full Text] [Related]
17. [ABNORMAL HEMOGLOBIN AND FAMILIAL HEMOLYTIC ANEMIA WITH ERYTHROCYTIC INCLUSIONS AND BLACK URINES]. GOUDEMAND M, BISERTE G, HABAY D, VOISIN D. Nouv Rev Fr Hematol; 1964 Oct 07; 4():487-504. PubMed ID: 14188997 [No Abstract] [Full Text] [Related]
18. Therapeutic management and the effect of splenectomy in patients with haemolytic anaemia due to intracardiac valvular prosthesis and associated haemoglobinopathy. Silingardi V, Quaglino D. Haematologica; 1975 Mar 07; 60(1):62-72. PubMed ID: 806499 [No Abstract] [Full Text] [Related]
19. Urinary beta-aminoisobutyric acid excretion in thalassaemia. Fessas P, Koniavitis A, Zeis PM. J Clin Pathol; 1969 Mar 07; 22(2):154-7. PubMed ID: 5776546 [Abstract] [Full Text] [Related]
20. New updating into hemoglobinopathies. Fucharoen S, Winichagoon P. Int J Lab Hematol; 2012 Dec 07; 34(6):559-65. PubMed ID: 22762348 [Abstract] [Full Text] [Related] Page: [Next] [New Search]